DXCM
DEXCOM INC
NASDAQ · Healthcare · Medical - Devices · US
$79.93
+1.67%Next report
Analyst consensus
- Next report date
- Feb 11, 2027
- EPS estimate
- $0.73
- Revenue estimate
- $1.4B
Latest reported
- Last report date
- Oct 29, 2026
- EPS actual
- $0.70
- EPS estimate
- $0.61
- Revenue actual
- $1.3B
- Revenue estimate
- $1.3B
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 9
- EPS misses (12Q)
- 2
- EPS in line (12Q)
- 1
- Avg surprise (4Q)
- +11.3%
- Revenue beats (12Q)
- 9
Analyst ratings
Sell-side consensus
- Consensus
- Buy
- Price target
- $95
- PT range
- $82 – $115
- Analysts
- 14
13 Buy1 Hold0 Sell
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Oct 29, 2026 | $0.68 | $0.73 | Beat 7.35% | $1.3B |
| Jul 30, 2026 | $0.61 | $0.70 | Beat 14.38% | $1.3B |
| Apr 30, 2026 | $0.47 | $0.56 | Beat 19.40% | $1.2B |
| Feb 12, 2026 | $0.65 | $0.68 | Beat 5.10% | $1.3B |
| Oct 30, 2025 | $0.57 | $0.61 | Beat 6.46% | $1.2B |
| Jul 30, 2025 | $0.44 | $0.48 | Beat 8.35% | $1.2B |
| May 1, 2025 | $0.33 | $0.32 | Miss -2.44% | $1.0B |
| Feb 13, 2025 | $0.48 | $0.45 | Miss -6.64% | $1.1B |
| Oct 24, 2024 | $0.45 | $0.45 | Beat 0.67% | $994.2M |
| Jul 25, 2024 | $0.39 | $0.43 | Beat 9.14% | $1.0B |
| Apr 25, 2024 | $0.27 | $0.32 | Beat 18.08% | $921.0M |
| Feb 8, 2024 | $0.43 | $0.50 | Beat 14.94% | $1.0B |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Feb 11, 2027